2010
DOI: 10.5125/jkaoms.2010.36.3.206
|View full text |Cite
|
Sign up to set email alerts
|

Consideration for treatment of bisphosphonate-related osteonecrosis of the jaw

Abstract: (J Korean Assoc Oral Maxillofac Surg 2010;36:206-10) Ⅰ. 서 론 Bisphosphonates are widely used to treat osteoporosis, hypercalcemia of malignant tumor. Despite their clinical benefit, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a newly documented complication to patients receiving these drugs and first recognized by Marx in 2003. Thus, consideration of prevention and needs regarding unequivocal treatment regimen have emerged. Recently, several authors emphasized reports on appropriate clinical a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 30 publications
0
0
0
Order By: Relevance